Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children

Item

http://www.wikidata.org/entity/Q36486823

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@ast

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@en

type

Item

label

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@ast

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@en

prefLabel

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@ast

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@en

P1476

Humoral, mucosal, and cell-med ...... ccine to HIV-infected children

@en

P2093

Adriana Weinberg

http://www.w3.org/2001/XMLSchema#string

Alfred Saah

http://www.w3.org/2001/XMLSchema#string

Anna B Moscicki

http://www.w3.org/2001/XMLSchema#string

IMPAACT/PACTG P1047 Team

http://www.w3.org/2001/XMLSchema#string

Janine Bryan

http://www.w3.org/2001/XMLSchema#string

Lin-Ye Song

http://www.w3.org/2001/XMLSchema#string

Martha Brown

http://www.w3.org/2001/XMLSchema#string

Myron J Levin

http://www.w3.org/2001/XMLSchema#string

William A Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.

Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

P304

1309-1318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIS489

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230616708

http://www.w3.org/2001/XMLSchema#string

P698

22859825

http://www.w3.org/2001/XMLSchema#string

P932

3529604

http://www.w3.org/2001/XMLSchema#string